CNC — Centene Corporation

Centene Corporation Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Diluted EPS: $3.37, exceeding expectations and prompting an increase in full-year guidance to greater than $3.40 (up from greater than $3.00).
• Premium and Service Revenue: $44.7 billion for Q1.
• Consolidated HBR (Health Benefit Ratio): 87.3% for Q1, with Medicaid at 93.1%, Medicare at 84.9%, and Marketplace slightly higher than expected.
• Medicaid Membership: 12.4 million, slightly down from year-end.
• Cash Flow from Operations: $4.4 billion, driven by strong net earnings.
• Debt-to-Capital Ratio: Improved to 43.2% from 46.5% at year-end.

2. Strategic Updates and Business Highlights

• Medicaid Business: Achieved margin improvement through targeted initiatives, with a focus on trend management and operational efficiencies.
• Medicare Segment: Strong performance in both Medicare Advantage and PDP, with a favorable membership mix and improved retention rates.
• Marketplace: Ended Q1 with 3.6 million members, consistent with expectations. Notable insights from the March Wakely report suggest a favorable risk adjustment outlook.
• Leadership Changes: Dan Finke appointed Group President for Medicaid and Commercial businesses; Michael Carson elevated to Group President for Medicare PDP and Specialty businesses.
• Fraud, Waste, and Abuse Initiatives: Continued focus on improving program integrity and reducing costs through enhanced analytics and collaboration with state partners.

3. Forward Guidance and Outlook

• Full-Year 2026 Guidance: Adjusted EPS expected to be greater than $3.40, with Medicaid composite rate yield around 4.5%.
• Marketplace Margin: Currently forecasted at approximately 3%, with potential upside depending on risk adjustment outcomes.
• Medicaid Membership: Expected to decline by about 6% from year-end to year-end.

4. Bad News, Challenges, or Points of Concern

• Pockets of Deceleration: Some areas of trend management are showing signs of deceleration, particularly in behavioral health.
• Medicaid Margin Recovery: While improvements are noted, there remains a significant gap to reach target margins.
• Market Volatility: Ongoing uncertainties related to risk adjustment and the impact of federal regulations on Medicaid and Marketplace operations.
• Debt Refinancing: Upcoming maturities in 2027 and 2028 may require refinancing at potentially higher rates.

5. Notable Q&A Insights

• Higher Acuity in Silver Tier: The shift in membership demographics post-APTC expiration has led to a higher acuity cohort in the Silver tier, which may positively impact risk adjustment.
• State Rate Discussions: Constructive conversations with states regarding Medicaid rates, with a focus on aligning rates with member acuity and trend data.
• Marketplace Risk Adjustment: The company is cautiously optimistic about risk adjustment benefits, though not fully accounting for potential offsets in current guidance.
• Fraud Management: Discussions highlighted the potential for states to leverage fraud management as a way to stabilize rates without increasing costs.

Overall, Centene's Q1 2026 results reflect a strong start to the year with positive momentum across its segments, though challenges remain in managing trends and navigating regulatory pressures.